[go: up one dir, main page]

BR9709418A - Aperfeiçoamento em composições contendo creatina ou em relação ás mesmas - Google Patents

Aperfeiçoamento em composições contendo creatina ou em relação ás mesmas

Info

Publication number
BR9709418A
BR9709418A BR9709418-8A BR9709418A BR9709418A BR 9709418 A BR9709418 A BR 9709418A BR 9709418 A BR9709418 A BR 9709418A BR 9709418 A BR9709418 A BR 9709418A
Authority
BR
Brazil
Prior art keywords
creatine
improvement
compositions containing
composition
conveniently
Prior art date
Application number
BR9709418-8A
Other languages
English (en)
Other versions
BR9709418B1 (pt
Inventor
Alan Norman Hohard
Original Assignee
Howard Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309414&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9709418(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Howard Foundation filed Critical Howard Foundation
Publication of BR9709418A publication Critical patent/BR9709418A/pt
Publication of BR9709418B1 publication Critical patent/BR9709418B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/385—Concentrates of non-alcoholic beverages
    • A23L2/39—Dry compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Confectionery (AREA)
  • Detergent Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Patente de Invenção:<B>"APERFEIçOAMENTO EM COMPOSIçõES CONTENDO CREATINA OU EM RELAçãO àS MESMAS"<D>. é descrita uma composição ácida para consumo humano, compreendendo creatina. De modo particular, a composição é convenientemente uma bebida isótonica para armazenagem a 4° C, ou é um pó seco estável que pode ser armazenado à temperatura ambiente.
BRPI9709418-8A 1996-05-31 1997-05-30 composição não terapêutica compreendendo creatina para consumo humano. BR9709418B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9611356.8A GB9611356D0 (en) 1996-05-31 1996-05-31 Improvements in or relating to compositions containing Creatine, and other ergogenic compounds
PCT/GB1997/001476 WO1997045026A1 (en) 1996-05-31 1997-05-30 Improvements in or relating to compositions containing creatine
ZA9710788A ZA9710788B (en) 1996-05-31 1997-12-01 Compositions containing creatine.

Publications (2)

Publication Number Publication Date
BR9709418A true BR9709418A (pt) 2000-01-11
BR9709418B1 BR9709418B1 (pt) 2011-03-09

Family

ID=26309414

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9709418-8A BR9709418B1 (pt) 1996-05-31 1997-05-30 composição não terapêutica compreendendo creatina para consumo humano.

Country Status (17)

Country Link
US (1) US5968544A (pt)
EP (1) EP0912110B1 (pt)
JP (1) JP3485576B2 (pt)
CN (2) CN1220583A (pt)
AT (1) ATE229280T1 (pt)
AU (1) AU733474B2 (pt)
BR (1) BR9709418B1 (pt)
CA (1) CA2253580C (pt)
DE (1) DE69717815T2 (pt)
EA (1) EA001388B1 (pt)
ES (1) ES2188945T3 (pt)
GB (2) GB9611356D0 (pt)
NO (1) NO315837B1 (pt)
NZ (1) NZ332408A (pt)
PL (1) PL330205A1 (pt)
WO (1) WO1997045026A1 (pt)
ZA (1) ZA9710788B (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274161B1 (en) 1996-05-31 2001-08-14 The Howard Foundation Compositions containing creatine in suspension
US8128955B2 (en) 1996-05-31 2012-03-06 The Original Creatine Patent Company Food compositions containing creatine
US6168802B1 (en) * 1996-05-31 2001-01-02 The Howard Foundation Compositions containing creatine and aloe vera extract
US6524611B2 (en) 1996-05-31 2003-02-25 The Howard Foundation Compositions containing creatine and creatinine
US7150880B2 (en) * 1996-05-31 2006-12-19 The Original Creatine Patent Co. Ltd. Compositions containing creatine and creatinine and a methyl xanthine
US5965596A (en) 1997-08-12 1999-10-12 Harris; Roger Methods and compositions for increasing the anaerobic working capacity in tissue
US7504376B2 (en) 1996-08-12 2009-03-17 Natural Alternatives International Methods and compositions for increasing the anaerobic working capacity in tissues
WO1998038183A1 (de) * 1997-02-26 1998-09-03 Skw Trostberg Aktiengesellschaft Kreatin-ascorbate und verfahren zu deren herstellung
DE19707694A1 (de) * 1997-02-26 1998-08-27 Sueddeutsche Kalkstickstoff Kreatin-ascorbate und Verfahren zu deren Herstellung
AU7755398A (en) * 1997-06-25 1999-01-19 Ipr-Institute For Pharmaceutical Research Ag Method for reducing body weight
TW404833B (en) * 1997-07-11 2000-09-11 Sueddeutsche Kalkstickstoff A method of producing calcium pyruvates
DE19729786A1 (de) * 1997-07-11 1999-01-14 Sueddeutsche Kalkstickstoff Verfahren zur Herstellung von Calciumpyruvaten
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
EP1051914A1 (de) * 1999-05-08 2000-11-15 DSM Fine Chemicals Austria GmbH Verwendung von Kreatin als Futterzusatz
EP1198182A1 (en) 1999-07-06 2002-04-24 Société des Produits Nestlé S.A. Isotonic juice drink for children
JP2001131065A (ja) * 1999-11-05 2001-05-15 Meiji Seika Kaisha Ltd 体脂肪減少促進剤及び体脂肪減少促進用食品組成物
GB0015617D0 (en) * 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
US6399661B1 (en) 2000-06-26 2002-06-04 Jeffrey M. Golini Oral creatine supplement and method for making same
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
MXPA03007757A (es) * 2001-03-02 2004-03-16 Howard Foundation Composiciones que contienen creatina y creatinina.
DE10133198A1 (de) * 2001-07-07 2003-01-23 Beiersdorf Ag Kreatin enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
DE10136077A1 (de) * 2001-07-25 2003-02-13 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einer Kombination von Kreatinin und/oder Kreatininderivaten mit Kreatin und/oder seinen Derivaten
DE10136076A1 (de) * 2001-07-25 2003-02-13 Beiersdorf Ag Verwendung von Kreatinin und/oder Kreatininderivaten in kosmetischen oder dermatologischen Zubereitungen
US20040052852A1 (en) * 2001-09-25 2004-03-18 Michael Farber Carbohydrate-based delivery system for creatine and other bioactive ingredients
DE10159244A1 (de) * 2001-12-03 2003-06-18 Degussa Bioactives Deutschland Feste und stabile Kreatin/Citronensäure-Zusammensetzung(en) und Kohlenhydrat(e) bzw. deren Hydrate enthaltende Formulierung, Verfahren zu ihrer Herstellung und deren Verwendung
US7067150B2 (en) 2002-04-16 2006-06-27 Scepter Holdings, Inc. Delivery systems for functional ingredients
US20030211133A1 (en) * 2002-05-10 2003-11-13 Special Ops Nutrition, L.L.C. Ingestible composition for enhancing athletic performance
DE10301632A1 (de) * 2003-01-17 2004-07-29 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Kreatin, Kreatinin und/oder seinen Derivaten in Kombination mit Sojabohnenkeimextrakten
US6982098B1 (en) * 2003-05-30 2006-01-03 Fun Unlimited Inc. Nutritional weight loss agent and method
US20050100637A1 (en) * 2003-11-12 2005-05-12 Robert Murray Carbohydrate and electrolyte replacement composition
DE10355711A1 (de) * 2003-11-26 2005-06-16 Beiersdorf Ag Kosmetische und dermatologische Emulsionen, enthaltend Kreatin und/oder Kreatinin und Elektrolytkonzentrationen, einer Ionenstärke von mindestens 50 mmol/l
CA2577963C (en) * 2004-08-25 2015-10-06 Mtor Formulations Ltd. Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle
US8283327B2 (en) * 2005-03-19 2012-10-09 Kneller Bruce W Palatinose for enhancing dietary supplement and pharmaceutical delivery
WO2007073398A2 (en) 2005-05-23 2007-06-28 Natural Alternatives International Compositions and methods for the sustained release of beta-alanine
JP2007209231A (ja) * 2006-02-08 2007-08-23 Japan Organo Co Ltd クレアチン含有食品組成物
AU2006338839A1 (en) * 2006-02-23 2007-08-30 Iomedix Sleep International Srl Compositions and methods for the induction and maintenance of quality sleep
EP2023718A4 (en) * 2006-05-11 2010-04-21 Avicena Group Inc CREATINLIGATE COMPOUNDS AND APPLICATION METHOD THEREFOR
ES2483366T3 (es) 2007-12-13 2014-08-06 Vanda Pharmaceuticals Inc. Método y composición para el tratamiento de una afección mediada por el receptor de serotonina
US8729100B2 (en) * 2007-12-13 2014-05-20 Vanda Pharmaceuticals, Inc. Method and composition for treating an alpha adrenoceptor-mediated condition
DE102007062288A1 (de) 2007-12-21 2009-06-25 Alzchem Trostberg Gmbh Kreatin-Zubereitung und Verfahren zu deren Herstellung
US8435590B2 (en) 2008-11-24 2013-05-07 Stokely-Van Camp, Inc. Use of novel carbohydrates and carbohydrate blends to provide a sports beverage with increased absorption
US8350077B2 (en) 2008-12-24 2013-01-08 Vertex Closed Joint Stock Company Amides of creatine, method of their preparation, and remedy possessing a neuroprotective activity
US8703719B1 (en) 2009-05-18 2014-04-22 Bio-Engineered Supplements And Nutrition, Inc. Method and composition for improved muscle performance
RU2463800C2 (ru) * 2009-09-23 2012-10-20 Закрытое акционерное общество "Академия-Т" Сухой специализированный белково-углеводный продукт для питания спортсменов
JP6154136B2 (ja) 2009-12-29 2017-06-28 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド コンパニオン動物のためのピルベートを含む組成物、およびその使用法
JP6584777B2 (ja) * 2015-01-16 2019-10-02 太陽化学株式会社 水分電解質補給飲料用粉末組成物
US11617737B2 (en) * 2016-12-15 2023-04-04 Société des Produits Nestlé S.A. Compositions and methods that modulate vitamin D and bone mineral content in a companion animal
AU2018351158A1 (en) * 2017-10-18 2020-05-28 Glanbia Nutritionals (Ireland) Ltd. Shelf-stable nitrogenous organic acid compositions
US11246846B2 (en) 2017-10-23 2022-02-15 Michael S. Tempesta Trisodium citrate compositions having enhanced uptake across digestive mucosa
US11154499B2 (en) 2018-03-27 2021-10-26 Thermolife International, Llc Creatine and/or creatinine compositions and related methods
CN114630587B (zh) * 2019-08-23 2025-10-10 可口可乐公司 稳定肌酸饮料

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL155719B (nl) * 1967-01-20 1978-02-15 Unilever Nv Werkwijze ter bereiding van smaakstofmengsels met een vleessmaak.
NL8100815A (nl) * 1981-02-19 1982-09-16 Unilever Nv Werkwijze ter bereiding van 4-hydroxy-5-methyl-2,3-dihydrofuran-3-on, alsmede werkwijze voor het wijzigen van de organoleptische eigenschappen van levensmiddelen en de aldus verkregen levensmiddelen.
JPS5925663A (ja) * 1982-08-02 1984-02-09 Ajinomoto Co Inc ビ−フフレ−バ−調味料の製造法
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
US4772591A (en) * 1985-09-25 1988-09-20 Peritain, Ltd. Method for accelerated wound healing
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot
US5397786A (en) * 1993-01-08 1995-03-14 Simone; Charles B. Rehydration drink
AU5890394A (en) * 1993-02-03 1994-08-29 Steven Andrew Jennings Blends of glycine derivatives and sugars
JP3213666B2 (ja) * 1994-02-28 2001-10-02 治彦 末岡 クレアチン飲料の製造方法
IT1271687B (it) * 1994-08-04 1997-06-04 Flamma Spa Sali organici idrosolubili della creatina
ATE332127T1 (de) * 1994-11-08 2006-07-15 Avicena Group Inc Verwendung von kreatin oder kreatinanologen zur behandlung von huntington chorea, morbus parkinson und amyotrophen lateralsklerose
JP3581727B2 (ja) * 1994-11-11 2004-10-27 株式会社日立製作所 ディスクアレイコントローラ及びディスクアレイ装置
JP3595373B2 (ja) * 1995-02-20 2004-12-02 治彦 末岡 クレアチン飲料
IT1275434B (it) * 1995-05-19 1997-08-07 Farmila Farma Milano Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante

Also Published As

Publication number Publication date
NO985532L (no) 1999-01-26
EA199801076A1 (ru) 1999-04-29
AU2970997A (en) 1998-01-05
HK1019694A1 (en) 2000-02-25
DE69717815D1 (de) 2003-01-23
GB9611356D0 (en) 1996-08-07
NO315837B1 (no) 2003-11-03
ZA9710788B (en) 1998-08-26
CN1220583A (zh) 1999-06-23
GB2313544A (en) 1997-12-03
WO1997045026A1 (en) 1997-12-04
NZ332408A (en) 1999-08-30
DE69717815T2 (de) 2003-11-20
PL330205A1 (en) 1999-04-26
GB2313544B (en) 2000-01-12
JP3485576B2 (ja) 2004-01-13
GB9711041D0 (en) 1997-07-23
ATE229280T1 (de) 2002-12-15
JP2000511054A (ja) 2000-08-29
EP0912110A1 (en) 1999-05-06
CN1364430A (zh) 2002-08-21
CA2253580C (en) 2006-10-03
AU733474B2 (en) 2001-05-17
EP0912110B1 (en) 2002-12-11
EA001388B1 (ru) 2001-02-26
US5968544A (en) 1999-10-19
NO985532D0 (no) 1998-11-27
CA2253580A1 (en) 1997-12-04
ES2188945T3 (es) 2003-07-01
BR9709418B1 (pt) 2011-03-09

Similar Documents

Publication Publication Date Title
BR9709418A (pt) Aperfeiçoamento em composições contendo creatina ou em relação ás mesmas
ZA9710122B (en) Improvements in or relating to organic compositions.
FR2746302B1 (fr) Compositions cosmetiques comprenant des nanopigments
ZA864608B (en) Amino acid derivatives
CA2294922A1 (en) Disposable absorbent articles maintaining low vapour phase moisture content
ZA979897B (en) Improvements in or relating to organic compositions.
ZA991469B (en) Improvement in or relating to organic compositions.
IT1309133B1 (it) Perfezionamenti nelle luci elettriche o relativamente alle stesse.
DE69927795D1 (en) Temperaturstabile dna polymerase aus thermoanaerobacter thermohydrosulfuricus
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
MXPA03001552A (es) Composicion topica que contiene tretinoina y 4-hidroxianisol estable al almacenamiento.
BR9915049A (pt) Veìculo com memória para armazenar pares de valores consistindo em primeiros dados e trecho percorrido
ATE205386T1 (de) Einphasige,transparente wässrige zusammensetzung
BR9913971A (pt) Uso de um composto
AU8375891A (en) Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated polypeptide, and compositions containing the same
ZA98187B (en) Improvements in or relating to organic compositions.
ZA973172B (en) Improvements in or relating to organic compositions.
ITMI20030827A1 (it) Composizione farmaceutica contenente l&#39;associazione levodopa/carbidopa.
WO2001072798A3 (en) Regulation of human oatp2-related protein
KR980000432A (ko) 세린을 함유하는 화장료 조성물
BR8000715U (pt) Disposição introduzida em embalagem
RU99114892A (ru) Природный криопротектор
TH13539S1 (th) ภาชนะบรรจุ
ITFE930013U1 (it) Bacchette orientali meccanizzate.
DK9800271U3 (da) Poletter til opbevaring i nøglering

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/03/2011, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2310 DE 14-04-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/198 (2006.01), A23L 2/39 (2006.0